Published in Curr Opin Biotechnol on October 16, 2010
Natural product libraries to accelerate the high-throughput discovery of therapeutic leads. J Nat Prod (2011) 0.97
In Vitro Reconstitution of Metabolic Pathways: Insights into Nature's Chemical Logic. Synlett (2015) 0.81
Discovery and evaluation of thiazinoquinones as anti-protozoal agents. Mar Drugs (2013) 0.80
Biological Activities and Chemical Composition of Methanolic Extracts of Selected Autochthonous Microalgae Strains from the Red Sea. Mar Drugs (2015) 0.75
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
Natural products as sources of new drugs over the last 25 years. J Nat Prod (2007) 13.98
The genome of the African trypanosome Trypanosoma brucei. Science (2005) 11.48
Phylogenomics of the reproductive parasite Wolbachia pipientis wMel: a streamlined genome overrun by mobile genetic elements. PLoS Biol (2004) 7.95
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science (2005) 7.61
Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet (2007) 4.58
In vivo antimalarial activity of the beta-carboline alkaloid manzamine A. Antimicrob Agents Chemother (2000) 2.23
Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis (2009) 1.74
Marine actinomycetes: a new source of compounds against the human malaria parasite. PLoS One (2008) 1.67
Inhibitory activity of marine sponge-derived natural products against parasitic protozoa. Mar Drugs (2010) 1.52
Inhibition of heme detoxification processes underlies the antimalarial activity of terpene isonitrile compounds from marine sponges. J Med Chem (2001) 1.41
Schistosoma genomics: new perspectives on schistosome biology and host-parasite interaction. Annu Rev Genomics Hum Genet (2009) 1.35
Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability. PLoS Negl Trop Dis (2010) 1.26
Antimalarial peptides from marine cyanobacteria: isolation and structural elucidation of gallinamide A. J Nat Prod (2009) 1.25
Marine antimalarials. Mar Drugs (2009) 1.23
Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges. Mar Drugs (2010) 1.22
Dolabellane-type diterpenoids with antiprotozoan activity from a southwestern Caribbean gorgonian octocoral of the genus Eunicea. J Nat Prod (2010) 1.22
Bioactive bromophycolides R-U from the Fijian red alga Callophycus serratus. J Nat Prod (2010) 1.17
Leishmaniasis: drug resistance and natural products (review). Int J Mol Med (2008) 1.13
Antiparasitic, antineuroinflammatory, and cytotoxic polyketides from the marine sponge Plakortis angulospiculatus collected in Brazil. J Nat Prod (2008) 1.09
Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp. J Nat Prod (2007) 1.06
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi. Bioorg Med Chem (2010) 1.05
Manadoperoxides A-D from the Indonesian sponge Plakortis cfr. simplex. Further insights on the structure-activity relationships of simple 1,2-dioxane antimalarials. J Nat Prod (2010) 1.04
Bromopyrrole alkaloids as lead compounds against protozoan parasites. Mar Drugs (2010) 1.03
Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis. J Nat Prod (2008) 1.01
Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds. J Med Chem (2010) 1.01
beta-Resorcylic acid lactones from a Paecilomyces fungus. J Nat Prod (2010) 1.01
Drug resistance in Plasmodium: natural products in the fight against malaria. Mini Rev Med Chem (2009) 1.00
New bioactive halenaquinone derivatives from South Pacific marine sponges of the genus Xestospongia. Bioorg Med Chem (2010) 1.00
Alisiaquinones and alisiaquinol, dual inhibitors of Plasmodium falciparum enzyme targets from a New Caledonian deep water sponge. J Nat Prod (2008) 0.99
Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review). Int J Mol Med (2008) 0.98
Antitrypanosomal cyclic polyketide peroxides from the Australian marine sponge Plakortis sp. J Nat Prod (2010) 0.98
Cyanolide A, a glycosidic macrolide with potent Molluscicidal activity from the Papua New Guinea cyanobacterium Lyngbya bouillonii. J Nat Prod (2010) 0.97
Bioactive guanidine alkaloids from two Caribbean marine sponges. J Nat Prod (2009) 0.97
Agelasines J, K, and L from the Solomon Islands Marine Sponge Agelas cf. mauritiana. J Nat Prod (2008) 0.96
Antimalarial bromotyrosine derivatives from the Australian marine sponge Hyattella sp. J Nat Prod (2010) 0.95
Anti-infective discorhabdins from a deep-water alaskan sponge of the genus Latrunculia. J Nat Prod (2010) 0.95
The marine sponge Diacarnus bismarckensis as a source of peroxiterpene inhibitors of Trypanosoma brucei, the causative agent of sleeping sickness. J Nat Prod (2009) 0.95
Additional insights on the bastadins: isolation of analogues from the sponge Ianthella cf. reticulata and exploration of the oxime configurations. J Nat Prod (2010) 0.90
Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. J Nat Prod (2010) 0.90
Potent and selective antiplasmodial activity of the cyanobacterial alkaloid nostocarboline and its dimers. Bioorg Med Chem Lett (2008) 0.88
Gracilioethers A-C, antimalarial metabolites from the marine sponge Agelas gracilis. J Org Chem (2009) 0.88
Antiprotozoal steroidal saponins from the marine sponge Pandaros acanthifolium. J Nat Prod (2010) 0.88
Screening of agelasine D and analogs for inhibitory activity against pathogenic protozoa; identification of hits for visceral leishmaniasis and Chagas disease. Molecules (2009) 0.87
Ciliatamides A-C, bioactive lipopeptides from the deep-sea sponge Aaptos ciliata. J Nat Prod (2008) 0.87
Merobatzelladines A and B, anti-infective tricyclic guanidines from a marine sponge Monanchora sp. Org Lett (2009) 0.87
Diterpene formamides from the tropical marine sponge Cymbastela hooperi and their antimalarial activity in vitro. J Nat Prod (2009) 0.86
Malyngolide dimer, a bioactive symmetric cyclodepside from the panamanian marine cyanobacterium Lyngbya majuscula. J Nat Prod (2010) 0.85
Antiplasmodial activities of homogentisic acid derivative protein kinase inhibitors isolated from a Vanuatu marine sponge Pseudoceratina sp. Mar Drugs (2009) 0.85
New innovations for an old infection: antimalarial lead discovery from marine natural products during the period 2003-2008. Future Med Chem (2009) 0.84
Antiviral and anticancer optimization studies of the DNA-binding marine natural product aaptamine. Chem Biol Drug Des (2008) 0.84
Activity against Plasmodium falciparum of cycloperoxide compounds obtained from the sponge Plakortis simplex. J Antimicrob Chemother (2002) 0.84
Girolline: a potential lead structure for antiplasmodial drug research. Planta Med (2008) 0.84
Aberrarone: a gorgonian-derived diterpene from Pseudopterogorgia elisabethae. J Org Chem (2009) 0.84
Antiparasitic activity of marine pyridoacridone alkaloids related to the ascididemins. Planta Med (2003) 0.83
The aignopsanes, a new class of sesquiterpenes from selected chemotypes of the sponge Cacospongia mycofijiensis. Org Lett (2009) 0.82
Antiprotozoal activities of heterocyclic-substituted xanthones from the marine-derived fungus Chaetomium sp. J Nat Prod (2008) 0.82
Antimalarial activity of crambescidin 800 and synthetic analogues against liver and blood stage of Plasmodium sp. J Antibiot (Tokyo) (2006) 0.81
Cytotoxic and antiplasmodial substances from marine-derived fungi, Nodulisporium sp. and CRI247-01. Phytochemistry (2008) 0.79
Norselic acids A-E, highly oxidized anti-infective steroids that deter mesograzer predation, from the Antarctic sponge Crella sp. J Nat Prod (2009) 0.78
An antiplasmodial new (bis)indole alkaloid from the hard coral Tubastraea sp. Nat Prod Res (2009) 0.78
Corallolides A and B: bioactive diterpenes featuring a novel carbon skeleton. Org Lett (2009) 0.78
A New Antimalarial Polyether from a Marine Streptomyces sp. H668. Tetrahedron Lett (2008) 0.78
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell (2004) 4.98
Polyketide assembly lines of uncultivated sponge symbionts from structure-based gene targeting. Nat Chem Biol (2009) 1.75
Psymberin, a potent sponge-derived cytotoxin from Psammocinia distantly related to the pederin family. Org Lett (2004) 1.72
Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases. Chem Biol (2007) 1.58
Asperazine, a Selective Cytotoxic Alkaloid from a Sponge-Derived Culture of Aspergillus niger. J Org Chem (1997) 1.27
A new paradigm for the development of anticancer agents from natural products. J Exp Ther Oncol (2006) 1.27
Sponge-derived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties. J Med Chem (2007) 1.26
Probing the bioactive constituents from chemotypes of the sponge Psammocinia aff. bulbosa. J Nat Prod (2007) 1.26
Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase. J Org Chem (2003) 1.25
NMR strategy for unraveling structures of bioactive sponge-derived oxy-polyhalogenated diphenyl ethers. J Nat Prod (2009) 1.23
A new structural theme in the imidazole-containing alkaloids from a calcareous Leucetta sponge. J Org Chem (2004) 1.22
The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells. BMC Cell Biol (2002) 1.17
Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases. J Nat Prod (2003) 1.17
Assessing pressurized liquid extraction for the high-throughput extraction of marine-sponge-derived natural products. J Nat Prod (2010) 1.15
Structures and cytotoxic properties of trichoverroids and their macrolide analogues produced by saltwater culture of Myrothecium verrucaria. J Med Chem (2003) 1.14
Uniquely modified imidazole alkaloids from a calcareous Leucetta sponge. J Nat Prod (2003) 1.13
Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges. J Med Chem (2008) 1.13
Azonazine, a novel dipeptide from a Hawaiian marine sediment-derived fungus, Aspergillus insulicola. Org Lett (2010) 1.10
Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay. J Nat Prod (2007) 1.10
Variation in the alkaloids among indo-pacific Leucetta sponges. J Nat Prod (2003) 1.06
Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries. Bioorg Med Chem (2007) 1.06
Structure revision of spiroleucettadine, a sponge alkaloid with a bicyclic core meager in H-atoms. J Org Chem (2008) 1.06
Structures and cytotoxic properties of sponge-derived bisannulated acridines. J Org Chem (2002) 1.05
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi. Bioorg Med Chem (2010) 1.05
A reassignment of (-)-mycothiazole and the isolation of a related diol. J Nat Prod (2006) 1.04
Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants. Bioorg Med Chem (2011) 1.04
Investigation of brominated tryptophan alkaloids from two thorectidae sponges: Thorectandra and Smenospongia. J Nat Prod (2005) 1.04
Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes. J Nat Prod (2009) 1.02
Revisiting the sponge sources, stereostructure, and biological activity of cyclocinamide a. J Nat Prod (2008) 0.99
Linking chemical and microbial diversity in marine sponges: possible role for poribacteria as producers of methyl-branched fatty acids. Chembiochem (2010) 0.99
Redox inactivation of human 15-lipoxygenase by marine-derived meroditerpenes and synthetic chromanes: archetypes for a unique class of selective and recyclable inhibitors. J Am Chem Soc (2004) 0.98
A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products. J Nat Prod (2009) 0.98
Natural product libraries to accelerate the high-throughput discovery of therapeutic leads. J Nat Prod (2011) 0.97
Extending the record of meroditerpenes from Cacospongia marine sponges. J Nat Prod (2007) 0.97
A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica. J Nat Prod (2004) 0.97
Puupehenone congeners from an indo-pacific hyrtios sponge. J Nat Prod (2003) 0.95
The marine sponge Diacarnus bismarckensis as a source of peroxiterpene inhibitors of Trypanosoma brucei, the causative agent of sleeping sickness. J Nat Prod (2009) 0.95
Highly N-methylated linear peptides produced by an atypical sponge-derived Acremonium sp. J Nat Prod (2006) 0.94
Using jasplakinolide to turn on pathways that enable the isolation of new chaetoglobosins from Phomospis asparagi. J Nat Prod (2005) 0.94
Probing the activity differences of simple and complex brominated aryl compounds against 15-soybean, 15-human, and 12-human lipoxygenase. J Med Chem (2004) 0.94
Comparison of fascaplysin and related alkaloids: a study of structures, cytotoxicities, and sources. J Nat Prod (2004) 0.94
The unexpected isolation of CTP-431, a novel thiopyrone from the sponge Cacospongia mycofijiensis. J Org Chem (2008) 0.93
Using a kinase screen to investigate the constituents of the sponge Stelletta clavosa obtained from diverse habitats. Bioorg Med Chem (2004) 0.93
Discovery and development of anticancer agents from marine sponges: perspectives based on a chemistry-experimental therapeutics collaborative program. J Exp Ther Oncol (2012) 0.92
A chemical study of cyclic depsipeptides produced by a sponge-derived fungus. J Nat Prod (2006) 0.91
A further study of the cytotoxic constituents of a milnamide-producing sponge. Org Lett (2004) 0.91
Expanding the strategies in natural product studies of marine-derived fungi: a chemical investigation of penicillium obtained from deep water sediment. J Nat Prod (2004) 0.90
Additional insights on the bastadins: isolation of analogues from the sponge Ianthella cf. reticulata and exploration of the oxime configurations. J Nat Prod (2010) 0.90
A serendipitous discovery of isomotuporin-containing sponge populations of Theonella swinhoei. J Nat Prod (2007) 0.89
Pinpointing pseurotins from a marine-derived Aspergillus as tools for chemical genetics using a synthetic lethality yeast screen. J Nat Prod (2007) 0.88
Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries. Bioorg Med Chem (2012) 0.87
Pyrroloacridine alkaloids from Plakortis quasiamphiaster: structures and bioactivity. J Nat Prod (2007) 0.86
Histone deacetylase inhibitors as a tool to up-regulate new fungal biosynthetic products: isolation of EGM-556, a cyclodepsipeptide, from Microascus sp. Org Lett (2010) 0.85
The Structure and Probable Biogenesis of Helianane, a Heterocyclic Sesquiterpene, from the Indo-Pacific Sponge Haliclona?fascigera. J Org Chem (1997) 0.85
Biostructural features of additional jasplakinolide (jaspamide) analogues. J Nat Prod (2011) 0.84
Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases. Biochem Pharmacol (2013) 0.84
Structures and cytotoxic evaluation of new and known acyclic Ene-Ynes from an American Samoa Petrosia sp. Sponge. J Nat Prod (2013) 0.84
A distinctive structural twist in the aminoimidazole alkaloids from a calcareous marine sponge: isolation and characterization of leucosolenamines A and B. J Nat Prod (2007) 0.83
The marine sponge metabolite mycothiazole: a novel prototype mitochondrial complex I inhibitor. Bioorg Med Chem (2010) 0.83
An analysis of phakellin and oroidin structures stimulated by further study of an Agelas sponge. J Nat Prod (2004) 0.83
Stereochemical determination and bioactivity assessment of (S)-(+)-curcuphenol dimers isolated from the marine sponge Didiscus aceratus and synthesized through laccase biocatalysis. Bioorg Med Chem (2005) 0.83
Additional scalarane sesterterpenes from the sponge Phyllospongia papyracea. J Nat Prod (2007) 0.83
Scrutinizing the scaffolds of marine biosynthetics from different source organisms: Gram-negative cultured bacterial products enter center stage. J Nat Prod (2014) 0.83
Unusual C25 steroids produced by a sponge-derived Penicillium citrinum. Org Lett (2003) 0.82
New structures and bioactivity properties of jasplakinolide (jaspamide) analogues from marine sponges. J Med Chem (2010) 0.82
The aignopsanes, a new class of sesquiterpenes from selected chemotypes of the sponge Cacospongia mycofijiensis. Org Lett (2009) 0.82
Utilizing DART mass spectrometry to pinpoint halogenated metabolites from a marine invertebrate-derived fungus. J Org Chem (2011) 0.81